Porter , Charles. “Tyrosine Kinase Inhibitors in Hematologic Malignancy: Should We Be Concerned?”. OncoReview 6, no. 1(21) (February 23, 2016): 11-13. Accessed July 6, 2024. https://journalsmededu.pl/index.php/OncoReview/article/view/470.